DL ADV-TECH, LLC

Pullman, WA · Medtech · Private

Europium-nanoparticles enhanced time-resolved fluorescent immunoassay biosensor for detecting wildfire exposure biomarkers in urine samples

Grants
$648K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Single-Atom Nanozyme Enhanced Handheld Biosensor for Measurement of Pesticide Exposures$146,867
Federal grantDepartment of Health and Human Services · Phase I · Rapid SARS-CoV-2 Spike Protein Neutralizing Antibody Tests for Evaluating COVID Vaccine-Generated Immunity$242,132
Federal grantDepartment of Health and Human Services · Phase I · Multiplexed biosensor for personal wildfire exposure assessment$258,999
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
834Surgical Training Simulators, Inc.—$200K
835Alexander International Innovations LLC—$200K
836HeartBeam, Inc.—$200K
837DL ADV-TECH, LLC——
838LAACClamp Inc.—$150K
839PRIMARY BIOSCIENCE, INC.—$100K
840PENSIEVISION, INC.—$100K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.